A Novel Human IgA Monoclonal Antibody Protects against Tuberculosis
Open Access
- 1 March 2011
- journal article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 186 (5), 3113-3119
- https://doi.org/10.4049/jimmunol.1003189
Abstract
Abs have been shown to be protective in passive immunotherapy of tuberculous infection using mouse experimental models. In this study, we report on the properties of a novel human IgA1, constructed using a single-chain variable fragment clone (2E9), selected from an Ab phage library. The purified Ab monomer revealed high binding affinities for the mycobacterial α-crystallin Ag and for the human FcαRI (CD89) IgA receptor. Intranasal inoculations with 2E9IgA1 and recombinant mouse IFN-γ significantly inhibited pulmonary H37Rv infection in mice transgenic for human CD89 but not in CD89-negative littermate controls, suggesting that binding to CD89 was necessary for the IgA-imparted passive protection. 2E9IgA1 added to human whole-blood or monocyte cultures inhibited luciferase-tagged H37Rv infection although not for all tested blood donors. Inhibition by 2E9IgA1 was synergistic with human rIFN-γ in cultures of purified human monocytes but not in whole-blood cultures. The demonstration of the mandatory role of FcαRI (CD89) for human IgA-mediated protection is important for understanding of the mechanisms involved and also for translation of this approach toward development of passive immunotherapy of tuberculosis.Keywords
This publication has 35 references indexed in Scilit:
- Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infectionInternational Journal of Medical Microbiology, 2009
- Prophylactic effect of administration of human gamma globulins in a mouse model of tuberculosisTuberculosis, 2009
- Functional and clinical consequences of Fc receptor polymorphic and copy number variantsClinical and Experimental Immunology, 2009
- Confronting the scientific obstacles to global control of tuberculosisJCI Insight, 2008
- IL‐4 depletion enhances host resistance and passive IgA protection against tuberculosis infection in BALB/c miceEuropean Journal of Immunology, 2007
- Therapeutic Efficacy of High-Dose Intravenous Immunoglobulin inMycobacterium tuberculosisInfection in MiceInfection and Immunity, 2005
- Evaluation of Human Antimycobacterial Immunity Using Recombinant Reporter MycobacteriaThe Journal of Infectious Diseases, 2000
- Recessive expression of the H2A-controlled immune response phenotype depends critically on antigen doseImmunology, 2000
- Identification of Residues in the CH2/CH3 Domain Interface of IgA Essential for Interaction with the Human Fcα Receptor (FcαR) CD89Journal of Biological Chemistry, 1999
- The human Fc receptor for IgA (FcαRI, CD89) on transgenic peritoneal macrophages triggers phagocytosis and tumor cell lysisImmunology Letters, 1999